NM_080390.4:c.17A>G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_080390.4(TCEAL2):c.17A>G(p.Asn6Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000415 in 1,204,239 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_080390.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TCEAL2 | ENST00000372780.6 | c.17A>G | p.Asn6Ser | missense_variant | Exon 3 of 3 | 1 | NM_080390.4 | ENSP00000361866.1 | ||
TCEAL2 | ENST00000476749.1 | n.802A>G | non_coding_transcript_exon_variant | Exon 2 of 2 | 1 | |||||
TCEAL2 | ENST00000329035.2 | c.17A>G | p.Asn6Ser | missense_variant | Exon 3 of 3 | 5 | ENSP00000332359.2 | |||
TCEAL2 | ENST00000651085.1 | n.153+402A>G | intron_variant | Intron 2 of 3 |
Frequencies
GnomAD3 genomes AF: 0.0000177 AC: 2AN: 112706Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34846
GnomAD3 exomes AF: 0.0000170 AC: 3AN: 176144Hom.: 0 AF XY: 0.0000160 AC XY: 1AN XY: 62476
GnomAD4 exome AF: 0.00000275 AC: 3AN: 1091533Hom.: 0 Cov.: 31 AF XY: 0.00000278 AC XY: 1AN XY: 359345
GnomAD4 genome AF: 0.0000177 AC: 2AN: 112706Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34846
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.17A>G (p.N6S) alteration is located in exon 3 (coding exon 1) of the TCEAL2 gene. This alteration results from a A to G substitution at nucleotide position 17, causing the asparagine (N) at amino acid position 6 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at